Pouniotis DS - Search Results

1

Cell-penetrating peptides: application in vaccine delivery.

Brooks NA, Pouniotis DS, Tang CK, Apostolopoulos V, Pietersz GA. Brooks NA, et al. Among authors: pouniotis ds. Biochim Biophys Acta. 2010 Jan;1805(1):25-34. doi: 10.1016/j.bbcan.2009.09.004. Epub 2009 Sep 25. Biochim Biophys Acta. 2010. PMID: 19782720 Review.

2

Penetratin tandemly linked to a CTL peptide induces anti-tumour T-cell responses via a cross-presentation pathway.

Pouniotis DS, Apostolopoulos V, Pietersz GA. Pouniotis DS, et al. Immunology. 2006 Mar;117(3):329-39. doi: 10.1111/j.1365-2567.2005.02304.x. Immunology. 2006. PMID: 16476052 Free PMC article.

3

Delivery of antigen using a novel mannosylated dendrimer potentiates immunogenicity in vitro and in vivo.

Sheng KC, Kalkanidis M, Pouniotis DS, Esparon S, Tang CK, Apostolopoulos V, Pietersz GA. Sheng KC, et al. Among authors: pouniotis ds. Eur J Immunol. 2008 Feb;38(2):424-36. doi: 10.1002/eji.200737578. Eur J Immunol. 2008. PMID: 18200633 Free article.

4

A membrane penetrating multiple antigen peptide (MAP) incorporating ovalbumin CD8 epitope induces potent immune responses in mice.

Brooks NA, Pouniotis DS, Sheng KC, Apostolopoulos V, Pietersz GA. Brooks NA, et al. Among authors: pouniotis ds. Biochim Biophys Acta. 2010 Dec;1798(12):2286-95. doi: 10.1016/j.bbamem.2010.05.007. Epub 2010 May 15. Biochim Biophys Acta. 2010. PMID: 20478265 Free article.

5

Whole protein and defined CD8(+) and CD4(+) peptides linked to penetratin targets both MHC class I and II antigen presentation pathways.

Pouniotis DS, Esparon S, Apostolopoulos V, Pietersz GA. Pouniotis DS, et al. Immunol Cell Biol. 2011 Nov;89(8):904-13. doi: 10.1038/icb.2011.13. Epub 2011 Mar 8. Immunol Cell Biol. 2011. PMID: 21383765

6

Design of peptide-based vaccines for cancer.

Pietersz GA, Pouniotis DS, Apostolopoulos V. Pietersz GA, et al. Among authors: pouniotis ds. Curr Med Chem. 2006;13(14):1591-607. doi: 10.2174/092986706777441922. Curr Med Chem. 2006. PMID: 16787206 Review.

7

Comparative Immunogenicity of a Cytotoxic T Cell Epitope Delivered by Penetratin and TAT Cell Penetrating Peptides.

Brooks N, Esparon S, Pouniotis D, Pietersz GA. Brooks N, et al. Molecules. 2015 Aug 3;20(8):14033-50. doi: 10.3390/molecules200814033. Molecules. 2015. PMID: 26247926 Free PMC article.

8

Vaccine delivery by penetratin: mechanism of antigen presentation by dendritic cells.

Pouniotis D, Tang CK, Apostolopoulos V, Pietersz G. Pouniotis D, et al. Immunol Res. 2016 Aug;64(4):887-900. doi: 10.1007/s12026-016-8799-5. Immunol Res. 2016. PMID: 27138940

9

Immunogenicity of a Tripartite Cell Penetrating Peptide Containing a MUC1 Variable Number of Tandem Repeat (VNTR) and A T Helper Epitope.

Brooks N, Hsu J, Esparon S, Pouniotis D, Pietersz GA. Brooks N, et al. Molecules. 2018 Sep 2;23(9):2233. doi: 10.3390/molecules23092233. Molecules. 2018. PMID: 30200528 Free PMC article.

10

Delivery of tumor associated antigens to antigen presenting cells using penetratin induces potent immune responses.

Apostolopoulos V, Pouniotis DS, van Maanen PJ, Andriessen RW, Lodding J, Xing PX, McKenzie IF, Loveland BE, Pietersz GA. Apostolopoulos V, et al. Among authors: pouniotis ds. Vaccine. 2006 Apr 12;24(16):3191-202. doi: 10.1016/j.vaccine.2006.01.032. Epub 2006 Jan 25. Vaccine. 2006. PMID: 16480791

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

38 results

Search Page